Profile cover photo
Profile photo
Edmund Lee
169 followers
169 followers
About
Edmund's posts

Post has attachment

Post has attachment

Post has attachment
Stem cell scientists develop more effective way to create motor neurons
Source: Stem cell scientists develop more effective way to create motor neurons Stem cell scientists develop more effective way to create motor neurons
by Mirabai Vogt-James
Stem cell scientists develop more effective way to create motor neurons
Often descr...

Post has attachment
Gene Therapy Stops, Stabilizes Spinal Muscular Atrophy
http://www.neurologyadvisor.com/gene-therapy-stabilizes-spinal-muscular-atrophy/article/392690/

Researchers from The Ohio State University, Nationwide Children's Hospital and the University of Bern in Switzerland found that protein replacement gene therapy...

Post has attachment
'Deep learning' reveals unexpected genetic roots of cancers, autism and other disorders
http://medicalxpress.com/news/2014-12-deep-reveals-unexpected-genetic-roots.html


Frey’s team used computational deep learning techniques to train a system that mimics the process of splicing in the cell (left panel). Features such as motifs, RNA secondary...

Post has attachment
Researcher develops new potential spinal muscular atrophy treatment
http://www.healio.com/spine-surgery/spinal-cord-and-nerves/news/online/%7Bd94d3efb-ddec-4de0-8b9b-5bdfd3985846%7D/researcher-develops-new-spinal-muscular-atrophy-treatment

A researcher at the University of Missouri has developed a new compound found to be ...

Post has attachment
CSF-Delivered Gene Therapy Shows Promise for Spinal Muscular Atrophy
http://www.prnewswire.com/news-releases/csf-delivered-gene-therapy-shows-promise-for-spinal-muscular-atrophy-281667421.html

ELK GROVE VILLAGE, Ill., Nov. 5, 2014 /PRNewswire-USNewswire/ -- A manuscript from the laboratory of Dr. Brian Kaspar of Nationwide ...

Post has attachment
ISIS PHARMACEUTICALS REPORTS DATA FROM ISIS-SMNRX PHASE 2 STUDIES IN INFANTS AND CHILDREN WITH SPINAL MUSCULAR ATROPHY
Email from SMA Foundation Below:


ISIS PHARMACEUTICALS REPORTS DATA FROM ISIS-SMNRX PHASE 2 STUDIES IN INFANTS AND CHILDREN WITH SPINAL MUSCULAR ATROPHY



Phase 3 ENDEAR study in infants with SMA enrolling; on track to initiate Phase 3 study in children ...

Post has attachment
AveXis Receives Orphan Drug Status from the US Food and Drug Administration (FDA) for chariSMA for the Treatment of Spinal Muscular Atrophy
Dallas, TX, October 04, 2014 --(PR.com)-- AveXis Inc., a synthetic biology platform company primarily focused on developing treatments for Spinal Muscular Atrophy (SMA) today announced that the U.S. Food and Drug Administration (FDA) has granted orphan drug...

Post has attachment
MU researchers make new breakthrough in spinal muscular atrophy drug
According to recent studies, approximately one out of every 40 individuals in the United States is a carrier of the gene responsible for spinal muscular atrophy (SMA), a neurodegenerative disease that causes muscles to weaken over time. Now, researchers at ...
Wait while more posts are being loaded